https://www.selleckchem.com/pr....oducts/fenebrutinib-
Evidence for any dysplasia, colon segment resection, aneuploidy, male sex, and age was classified as weak. In addition, histologic inflammation was identified as a risk factor in multivariable analysis (weak evidence). The evidence for the protective factors colonoscopic surveillance, 5-Aminosalicylic Acid, thiopurines, and smoking was moderate in univariable analysis. Multivariable analysis provided weak evidence for statin use. In this systematic review and meta-analysis, we identified 13 risk factors and 5 protective fa
Like
Comment
Share
